The judge ruled the "unjust enrichment" suit failed to even plausibly allege the "enrichment" of Abbott Labs — let alone the ...
Until the U.S. addresses the extreme concentration in the infant formula industry, the country is just one plant closure away ...
CHICAGO — A federal court in Illinois dismissed a nationwide class action brought by consumers against Abbott Labs, whose baby formula prices spiked during a 2022 recall of tainted formula. The court ...
Following an Illinois jury ordering Reckitt Benckiser Group to pay $60 million in damages over allegations that its infant formula led to the death of a premature baby, Abbott Laboratories CEO ...
When the FDA recently ... judgment of the Abbott product. The agency takes too narrow a view of what should be disqualifying, she said. One committee member was Craig Selzman, chief of the ...
Abbott Laboratories received U.S. FDA approval for its Esprit below-the-knee (BTK) everolimus-eluting resorbable scaffold system for use in chronic limb-threatening ischemia well ahead of the expected ...
Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. The company received a groundbreaking FDA approval for its latest drug-eluting scaffold ...
Abbott earned a groundbreaking FDA approval on Monday for its dissolving stent designed to unclog arteries below the knee. The device, called the Esprit BTK System, is meant to treat patients who ...
said the FDA shouldn’t have allowed recipients of funding from Abbott in recent years to sit in judgment of the Abbott product. The agency takes too narrow a view of what should be disqualifying, she ...